Nebraska Cultivators Ask State to Change Testing, Fee, Doctor Rules

Cultivators Want Three Rule Areas Revisited

Nebraska cultivators have asked state officials to change rules on testing, fees and doctor protections, according to Marijuana Moment on Oct. 21, 2026. That headline is the verifiable core of the story.

Three subjects. One audience: state regulators.

The Public Record Is Thin on Specifics

The source material doesn't identify the rule sections, fee amounts or testing thresholds in dispute. We won't guess at them.

Until the underlying comments are public, these are categories, not proposals. On a strict reading, a category isn't a rule change.

Testing Rules Decide Whether a Harvest Is Inventory or a Write-Off

Testing standards allocate risk among growers, labs and regulators. A cultivator carries the cost of a failed batch, so any request to change testing rules is a request to move that exposure.

What the cultivators want changed on testing isn't specified in the signal. That's the first detail to pin down.

Fees Carry a Tax Consequence Ordinary Businesses Don't Face

Under IRC §280E, fee relief does more work for a cannabis operator than for a comparable manufacturer. As written, §280E disallows deductions for businesses trafficking in Schedule I or II controlled substances, other than cost of goods sold.

Whether a given Nebraska licensing or renewal fee can be folded into cost of goods sold is a fact-specific question for each operator's tax counsel, and whether §280E applies at all turns on federal scheduling. If a fee can't be capitalized into inventory, the operator absorbs it in full. That math is hard to argue with.

Doctor Protections Drive Demand

A medical program only produces customers if clinicians are willing to participate. The headline doesn't say which protections cultivators want, or from what risk.

Still, growers asking for clinician safeguards signals they see physician hesitancy as a threat to their sales volume.

A Taxonomy of the Three Asks

Each request touches a different part of the cultivator's ledger.

• Testing: operational and batch-loss risk
• Fees: cash costs and §280E exposure
• Doctor protections: patient volume and demand

For full background on this story, see the CannIntel topic hub on the Nebraska Medical Cannabis Program.

What to Watch Next

The next useful document is the cultivators' actual written request. We'll be watching for specific rule citations and dollar figures, and for any response from Nebraska regulators that shows which of the three asks gets traction first.